I had thought this too, but think that even with FDA approval on pediatric applications alone, the market cap should be higher than today. No doubt a bad adult trail will hurt so in the short term. Long term, even with pediatric alone, share price should be much higher
RAP charting, page-2962
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 5,464 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)